Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05873296
Other study ID # UFMA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2023
Est. completion date December 30, 2023

Study information

Verified date May 2023
Source Federal University of Maranhao
Contact Andréa D Reis
Phone +55 98987220570
Email andrea.dr@ufma.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The sedentary lifestyle in women with breast cancer generates a problem for public health. An alternative that has been used to reduce sedentary behavior are interventions with the use of information technology, as well as projects with health education can cause lifestyle changes. However, little is known about the effect of these interventions on self-awareness and self-care in women with breast cancer. This aim of study is evaluate the effect of health education on sedentary behavior, lifestyle, physical activity level, nutrition, self-esteem, anxiety and depression, quality of life, pain, functional capacity, and strength in women with breast cancer. This is a study the 12 weeks, with patients being treated for breast cancer, distributed for two groups: Group Health Education Recommendations and Control Group.


Description:

This is a clinical trial with patients being treated for breast cancer, the sample will be randomly distributed into two groups: Group Health Education Recommendations (GRES) and Control Group (CG), which will remain in usual care. The intervention will last for 12 weeks, where GRES will receive health education recommendations in person and via social media. The endpoints of this study are sedentary behavior, lifestyle, physical activity level, nutrition, self-esteem, anxiety and depression, quality of life, pain, functional capacity, and strength. Evaluations will be performed at baseline, after 6 weeks, and after 12 weeks. Data will be analyzed by multivariate, comparing the effects of group, time, and interaction in SPSS software version 24.0, with α=5%.


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date December 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Women 18 years or older; - Diagnosed with breast cancer; - Ongoing breast cancer treatment (chemotherapy, radiotherapy and/or hormone therapy); - Have daily access to a smartphone. Exclusion Criteria: - Women having another type of cancer; - Perform physical training for three months before the intervention; - Has medical contraindication to perform any type of physical activity; - Have filled in yes on the PAR-Q and medical contraindication; - Without cognitive conditions to use a smartphone or answer questionnaires; - Illiterate women.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Health Education
The intervention will last for 12 weeks, a health education program (face-to-face meetings and information in social networks).

Locations

Country Name City State
Brazil Andréa Dias Reis São Luís Maranhão

Sponsors (1)

Lead Sponsor Collaborator
Federal University of Maranhao

Country where clinical trial is conducted

Brazil, 

References & Publications (4)

Fridriksdottir N, Gunnarsdottir S, Zoega S, Ingadottir B, Hafsteinsdottir EJG. Effects of web-based interventions on cancer patients' symptoms: review of randomized trials. Support Care Cancer. 2018 Feb;26(2):337-351. doi: 10.1007/s00520-017-3882-6. Epub 2017 Sep 18. — View Citation

Gao Z, Ryu S, Chen Y. Effects of Tai Chi App and Facebook health education programs on breast cancer survivors' stress and quality of life in the Era of pandemic. Complement Ther Clin Pract. 2022 Aug;48:101621. doi: 10.1016/j.ctcp.2022.101621. Epub 2022 Jun 16. — View Citation

Ghosn B, Benisi-Kohansal S, Ebrahimpour-Koujan S, Azadbakht L, Esmaillzadeh A. Association between healthy lifestyle score and breast cancer. Nutr J. 2020 Jan 14;19(1):4. doi: 10.1186/s12937-020-0520-9. — View Citation

Hardcastle SJ, Maxwell-Smith C, Kamarova S, Lamb S, Millar L, Cohen PA. Factors influencing non-participation in an exercise program and attitudes towards physical activity amongst cancer survivors. Support Care Cancer. 2018 Apr;26(4):1289-1295. doi: 10.1007/s00520-017-3952-9. Epub 2017 Oct 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Life habits Lifestyle will be evaluated by Individual Lifestyle Profile Questionnaire Change from baseline, 6 weeks Life habits at 12 weeks
Secondary Body composition (lean mass, fat mass) Body Composition will be evaluated by Sanny Tetrapolar Bioimpedance (Model 1011) Change from baseline, 6 weeks Body composition at 12 weeks
Secondary Sitting time Sedentary behavior will be evaluated by triaxial accelerometers motion sensor Actigraph GT3X model Change from baseline, 6 weeks Sitting time at 12 weeks
Secondary Time and level the physical activity Physical activity level will be evaluated by triaxial accelerometers motion sensor Actigraph, GT3X model. Change from baseline, 6 weeks Time and level the physical activity at 12 weeks
Secondary Level the self-esteem Self-esteem will be evaluated by Rosenberg Self-Esteem Scale (score 1 to 4 - higher score is better and worse outcome, depends on the question) Change from baseline, 6 weeks Level the self-esteem at 12 weeks
Secondary Dimensions the quality of Life from cancer Quality of Life will be evaluated by European Organization for Research and Treatment of Cancer Quality of Life Questionnarie - 30 questions (score 1 to 4 - higher score is worse outcome) Change from baseline, 6 weeks Dimensions the quality of Life at 12 weeks
Secondary Dimensions the quality of Life from breast cancer Quality of Life will be evaluated by European Organization for Research and Treatment of Cancer Quality of Life Questionnarie - 23 questions (score 1 to 4 - higher score is worse outcome) Change from baseline, 6 weeks Dimensions the quality of Life at 12 weeks
Secondary Level the pain Pain will be evaluated by Brief Pain Inventory (score 1 to 10 - higher score is worse outcome) Change from baseline, 6 weeks Level the pain at 12 weeks
Secondary Eating habits Eating behavior will be evaluated by (score 1 to 4 - higher score is better outcome) Change from baseline, 6 weeks Eating habits at 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03080623 - Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion
Completed NCT05527769 - Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique
Completed NCT06376578 - Exercise Interventions for Improving Health in Breast Cancer Survivors N/A
Completed NCT03004534 - A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide Early Phase 1
Recruiting NCT05020574 - Microbiome and Association With Implant Infections Phase 2
Active, not recruiting NCT06277141 - The Vitality Mammography Messaging Study N/A
Completed NCT03555227 - USG PECS vs LIA for Breast Cancer Surgery N/A
Completed NCT03270111 - High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women N/A
Active, not recruiting NCT03917082 - Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer Phase 2
Recruiting NCT05561842 - Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Completed NCT04554056 - Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF Phase 2/Phase 3
Active, not recruiting NCT03127995 - Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence N/A
Active, not recruiting NCT02237469 - Prone Breast Radiotherapy Treatment Planning Observational Study
Completed NCT01204125 - Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients Phase 2
Recruiting NCT04565054 - Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC Phase 3
Not yet recruiting NCT06412133 - Conversations in Light and Shadow: Assessing Phototherapy's Impact on Breast Cancer Patients N/A
Recruiting NCT03956641 - Evolution of the Physical Condition in Treated Cancer Patients N/A
Recruiting NCT06087120 - Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting NCT06058936 - Exercises Using Virtual Reality on Cancer Patients N/A
Completed NCT03470935 - Non-interventional Study Evaluating Gynecological Impact of Diagnosis and Treatment of Breast Cancer in Patients Younger